製品名:(2-Acetyl-4-methylpentyl)trimethylammonium Iodide

IUPAC Name:trimethyl[2-(2-methylpropyl)-3-oxobutyl]azanium iodide

CAS番号:1069-62-1
分子式:C11H24INO
純度:95%+
カタログ番号:CM414743
分子量:313.22

包装単位 有効在庫 価格(USD) 数量
CM414743-1g in stock ŹƓ
CM414743-5g in stock ƿůȃ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:1069-62-1
分子式:C11H24INO
融点:-
SMILESコード:[I-].CC(C)CC(C[N+](C)(C)C)C(C)=O
密度:
カタログ番号:CM414743
分子量:313.22
沸点:
MDL番号:MFCD28143141
保管方法:

Column Infos

Valbenazine
Neurocrine Biosciences announced interim results from the ongoing open-label KINECT®-HD2 study about INGREZZA® (Valbenazine) capsules when used for the long-term treatment of adults with chorea associated with Huntington's disease (HD). Interim data suggest one-capsule, once-daily INGREZZA improved chorea at the first evaluation at Week 2 with sustained efficacy through Week 50. INGREZZA® (Valbenazine) is the only one-capsule, once-daily selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved by FDA for the treatment of adults with tardive dyskinesia and the treatment of chorea associated with Huntington's disease (HD).
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products